Skip to main content

Table 1 PROMIS II patient characteristics at baseline

From: Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium study

 

N(%), or Mean(std)

Disease duration

 Incident, n(%)

60 (47)

 Prevalent, n(%)

67 (53)

Age

 8–12 years, n(%)

67 (53)

 13–17 years, n(%)

60 (47)

Female, n(%)

44 (35)

Race

 White, n(%)

65 (52)

 Black, n(%)

36 (28)

 Asian, n(%)

16 (13)

 Other, n(%)

10 (8)

Hispanic or Latino ethnicity, n(%)

10 (8)

Maternal Education

 < High School, n(%)

12 (9)

 High school, n(%)

46 (36)

 2-Year Associate’s Degree, n(%)

16 (13)

 4-Year College Degree, n(%)

24 (19)

 Graduate Degree, n(%)

7 (6)

 Unknown, n(%)

22 (17)

Obese, n(%)

44 (35)

Edema Present, n(%)

96 (76)

Hypertension, n(%)

53 (42)

Number of Symptoms, Mean(std)

4 (3)

Number of Medical Conditions, Mean(std)

1 (1)

Immunosuppressive therapy, n(%)

99 (78)

Emergency Department Visits in last 6 months (≥ 1 visit), n(%)

49 (39)

Hospitalizations in last 6 months (≥ 1 visit), n(%)

58 (46)

Estimated GFR (mL/min/1.73 m2), Mean(std)

113 (48)

Urine Protein:Creatinine, Mean(std)

6.7 (7.1)

Albumin, Mean(std)

2.4 (1.0)

Hemoglobin, Mean(std)

13.3 (2.0)

Number of medications, Mean(std)

3 (3)